Medical News / ACC House Call: Usability of Novel VTE Risk Score with Deepak Bhatt, MD

New data from the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC) suggest a novel 10-SNP genetic risk score shows promise for predicting the risk of venous thromboembolism (VTE) in patients with cardiometabolic disease. Created by a team of investigators from the TIMI Study Group, Harvard Medical School, and the Board Institute of MIT and Harvard, the novel risk score was designed and assessed in more than 30,000 patients with cardiometabolic disease from the FOURIER, PEGASUS-TIMI 54, and SAVOR-TIMI 53 trials. Source: MDMag. By reading more or clicking on the link below, you are leaving this site and going to another site run by another organization.

read more

MORE MEDICAL NEWS
Few surgical advances this century have had an impact equal to that of transcatheter aortic valve ... read more
While the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC) ... read more
Results of a new study are offering clinicians guidance on optimal timing of menopausal hormone replacement ... read more
The clinical discussion as to whether electronic cigarette devices has already begun. But debate still wages ... read more